Skip to main content

Articles

Page 37 of 38

  1. Prion diseases share common features of neurodegenerative disorders, infectious diseases and pathologies linked to misfolded proteins. Whether these aspects are independently and fortuitously present in prion ...

    Authors: Maurizio Pocchiari, Anna Poleggi, Serena Principe, Silvia Graziano and Franco Cardone
    Citation: Genome Medicine 2009 1:63
  2. DNA copy number variations (CNVs) are an important component of genetic variation, affecting a greater fraction of the genome than single nucleotide polymorphisms (SNPs). The advent of high-resolution SNP arra...

    Authors: Adam Shlien and David Malkin
    Citation: Genome Medicine 2009 1:62
  3. The message is loud and clear. MicroRNA-96, one in a cluster of three related neurosensory microRNAs, is crucial to the development and maintenance of inner ear hair cells and hearing in mice and humans. Two r...

    Authors: Michael D Weston and Garrett A Soukup
    Citation: Genome Medicine 2009 1:59
  4. Advances in mass spectrometry have had a great impact on the field of proteomics. A major challenge of proteomic analysis has been the elucidation of glycan modifications of proteins in complex proteomes. Glyc...

    Authors: Allen D Taylor, William S Hancock, Marina Hincapie, Naoyuki Taniguchi and Samir M Hanash
    Citation: Genome Medicine 2009 1:57
  5. Myeloproliferative neoplasms (MPNs) are a group of closely related stem-cell-derived clonal proliferative diseases. Most cases are sporadic but first-degree relatives of MPN patients have a five- to seven-fold...

    Authors: Lynn R Goldin, Magnus Björkholm, Sigurdur Y Kristinsson, Jan Samuelsson and Ola Landgren
    Citation: Genome Medicine 2009 1:55
  6. Atrial fibrillation (AF) is the most common persistent cardiac dysrhythmia and the number one cause of arrhythmia-related hospitalizations. In addition, AF is a major contributor to stroke. With life expectanc...

    Authors: Samir B Damani and Eric J Topol
    Citation: Genome Medicine 2009 1:54
  7. A 100 kb region on 9p21.3 harbors two major disease susceptibility loci: one for type 2 diabetes (T2D) and one for coronary heart disease (CHD). The single nucleotide polymorphisms (SNPs) associated with these...

    Authors: Kaisa Silander, Hua Tang, Sean Myles, Eveliina Jakkula, Nicholas J Timpson, Luigi Cavalli-Sforza and Leena Peltonen
    Citation: Genome Medicine 2009 1:51
  8. The availability of serum collections from the Women's Health Initiative (WHI) conjugated equine estrogens (CEE) randomized controlled trial provides an opportunity to test the potential of in-depth quantitati...

    Authors: Hiroyuki Katayama, Sophie Paczesny, Ross Prentice, Aaron Aragaki, Vitor M Faca, Sharon J Pitteri, Qing Zhang, Hong Wang, Melissa Silva, Jacob Kennedy, Jacques Rossouw, Rebecca Jackson, Judith Hsia, Rowan Chlebowski, JoAnn Manson and Samir Hanash
    Citation: Genome Medicine 2009 1:47
  9. Rhinovirus infections cause at least 70% of virus-related wheezing exacerbations and cold and flu-like illnesses. Infections are also associated with otitis media, sinusitis and pneumonia. The annual impact of...

    Authors: Katherine E Arden and Ian M Mackay
    Citation: Genome Medicine 2009 1:44
  10. It is now becoming generally accepted that a significant amount of human genetic variation is due to structural changes of the genome rather than to base-pair changes in the DNA. As for base-pair changes, know...

    Authors: James R Lupski
    Citation: Genome Medicine 2009 1:42
  11. Although microarray technology allows the investigation of the transcriptomic make-up of a tumor in one experiment, the transcriptome does not completely reflect the underlying biology due to alternative splic...

    Authors: Anneleen Daemen, Olivier Gevaert, Fabian Ojeda, Annelies Debucquoy, Johan AK Suykens, Christine Sempoux, Jean-Pascal Machiels, Karin Haustermans and Bart De Moor
    Citation: Genome Medicine 2009 1:39
  12. Though the field has moved with glacial speed, gene therapies have been carried out successfully in patients with bone marrow disorders including immune deficiencies. The field may be poised to move forward mo...

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:38
  13. Alzheimer's disease is a progressive neurodegenerative disorder with high prevalence in old age. It is the most common cause of dementia, with a risk reaching 50% after the age of 85 years, and with the increa...

    Authors: Dimitrios Avramopoulos
    Citation: Genome Medicine 2009 1:34
  14. Functional genomic studies are dominated by transcriptomic approaches, in part reflecting the vast amount of information that can be obtained, the ability to amplify mRNA and the availability of commercially s...

    Authors: Julian L Griffin and Christine Des Rosiers
    Citation: Genome Medicine 2009 1:32
  15. Despite the recent success of genome-wide association studies (GWASs) in identifying loci consistently associated with coronary artery disease (CAD), a large proportion of the genetic components of CAD and its...

    Authors: Matthew B Lanktree and Robert A Hegele
    Citation: Genome Medicine 2009 1:28
  16. Disparities in health outcomes of members of different ancestral or ethnic groups can be observed in both developed and developing countries and continue to be a global concern. Genomic medicine can help towar...

    Authors: David Gurwitz and Jeantine E Lunshof
    Citation: Genome Medicine 2009 1:24
  17. The wide general publication of a putative genetic test for athletic supremacy is clearly an abuse of genetics and reveals an undercurrent of hucksterism in biomedical science.

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:18
  18. The availability of personalized genomic tests, ordered directly by consumers, is rapidly growing. These tests are unlike other genetic or biochemical tests in the sheer amount of data they provide, but interp...

    Authors: David Magnus, Mildred K Cho and Robert Cook-Deegan
    Citation: Genome Medicine 2009 1:17
  19. The genome era in medicine is upon us. Questions that arise from patient and family care are a watershed for research and technology, which in turn fuel the cycle of opportunity for impact through delivery of ...

    Authors: Janet A Buchanan, Andrew R Carson, David Chitayat, David Malkin, M Stephen Meyn, Peter N Ray, Cheryl Shuman, Rosanna Weksberg and Stephen W Scherer
    Citation: Genome Medicine 2009 1:16

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 10.4
    5-year Journal Impact Factor: 12.6
    Source Normalized Impact per Paper (SNIP): 2.375
    SCImago Journal Rank (SJR): 4.975

    Speed 2023
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 185

    Usage 2023
    Downloads: 2,331,772
    Altmetric mentions: 4,916

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.